Table 1.
Localization | Phenotype | Functional characteristics | Reference | |
CD8 TRM | ||||
Gut | mice | Id3low Blimp1high | 50 | |
Id3high Blimp1 low | ||||
Human | CD103+CD69+ | Highly polyfunctional (IFN-γ+/IL-2+/TNF-α+) |
51 | |
β2integrin+CD103−CD69+ | Highly cytotoxic (GZMB+) | |||
IE | CD103+ KLRG1- CD28 low 2B4 high CD161high CD127high PD-1low |
Damped polyfunctionality Damped cytotoxicity |
40 | |
LP | CD103+ KLRG1- CD28low 2B4 high CD161high CD127 high PD-1low |
Highly polyfunctional (IFN-γ+/IL-2+/TNF-α+) GZMB+, Perforin+ |
||
CD103- KLRG1- CD28high CD161low CD127low PD-1 high NKG2D high |
Polyfunctional (IFN-γ+/IL-2+/TNF-α+) |
|||
CD103- KLRG1+ CD28 high CD161 low CD127 low PD-1 high NKG2D high |
Highly cytotoxic (GZMB+, Perforin+) |
|||
Liver | mice | CD69+ CD103- | Highly polyfunctional (IFN-γ+/IL-2+/TNF-α+) |
55 |
Human | CD69+CD103+ CXCR6+ CXCR3+ | High IL-2 production | 11 | |
Pancreas | Human | CD69+ CD103+ CD49a+ CD101+ PD-1+ |
GZMB+ Highly polyfunctional (IFN-γ+/IL-2+) |
16 |
Skin | mice | CD69+ CD103+ | Damped polyfunctionality (IFN-γ+/IL-2+/TNF-α+) |
55 |
CD69+ CD103+ CD49a+ | Increased IFN-γ production | 37 | ||
Salivary gland | mice | CD69+ CD103- CD69+ CD103+ |
Highly polyfunctional (IFN-γ+/IL-2+/TNF-α+) Damped polyfunctionality (IFN-γ+/IL-2+/TNF-α+) |
55 |
Lymph nodes | human | CD69+ CD103- | IFN-γ+, IL-2+ | 16 |
CD4 TRM | ||||
Liver | human | CD69 high CXCR6+ CD49a+ PD-1+ S1PR1- CD69 int CXCR3+ CX3CR1+ CXCR1+ |
TH1 cytokine production (IL-2, IFN-γ, IL-21) TH2 cytokine production (IL-4) |
56 |
Small intestine | human | CD69+ CD103+ 2B4+ CD49a+ CXCR6+ CD101+ CD161+ CD28low CD69+ CD103- KLRG1+ CD49a+ CXCR6+ CD101+ CD161+ CD28low |
TH1 cytokine production (IFN-γ+/IL-2+/TNF-α+) GZMB+, Perforin+, IL-17+ TH1 cytokine production (IFN-γ+/IL-2+/TNF-α+) Perforin+ |
57 |
IE, Intra-epithelial; LP, lamina propria.